Home Markets AXGT's Parkinson's Gene Therapy Trial To Be Delayed, BLCM To Trim Workforce,...

AXGT's Parkinson's Gene Therapy Trial To Be Delayed, BLCM To Trim Workforce, MRNA On Watch

4
investorsdiurnal business news magazine

This post was originally published on this site

(RTTNews) – Today's Daily Dose brings you news about Axovant's update on its EXPLORE-PD study of AXO-Lenti-PD gene therapy in Parkinson's disease, disappointing data from Bellicum's pancreatic cancer trial, vTv Therapeutics' progress in Elevage study, and the near-term catalysts related to Moderna's COVID-19 vaccine candidate.

Read on…

1.